07:00 , Aug 16, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Multiple sclerosis (MS) b-Amyloid 40; b-amyloid 42 Mouse studies suggest amyloid peptides could help treat MS. In four different mouse models of experimental autoimmune encephalitis...
07:00 , Aug 16, 2012 |  BC Innovations  |  Targets & Mechanisms

Amyloids for inflammation

Researchers at Stanford University have found that systemic treatment with b-amyloid peptides can reduce inflammation and reverse paralysis in mouse models of multiple sclerosis. 1 Cardinal Therapeutics Inc. has licensed the work and now is...
08:00 , Mar 1, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation Crystallin aB (CRYAB; HSPB5) In vitro studies identified a mechanism for HSPB5's anti-inflammatory activity that could help improve treatment of multiple sclerosis (MS). HspB5...